HOME > TOP STORIES
TOP STORIES
-
REGULATORY J&J’s Lazcluze, Genmab’s Tivdak, and More Up for MHLW Panel Review on Feb. 27
February 14, 2025
-
BUSINESS Regeneron to Upsize Japan Workforce after Libtayo Transfer
February 13, 2025
-
BUSINESS Cheplapharm Set to Expand LLP Deals to 20 APIs, Sees Opportunities Despite Headwinds
February 12, 2025
-
ORGANIZATION US Lobbies Send Letters of Protest to Japan Embassy over Off-Year Revision, CEA
February 10, 2025
-
BUSINESS Bain Picks Up Mitsubishi Tanabe for Over 500 Billion Yen
February 10, 2025
-
BUSINESS AstraZeneca Looks to Keep No.1 Spot in Japan Oncology Space, Driven by Bispecific Antibodies
February 7, 2025
-
BUSINESS Celltrion Set for 6 Biosimilar Filings in 2 Years, Sees Japanese Data Waiver as a Boon
February 6, 2025
-
REGULATORY Japan’s 1st Hemophilia B Gene Therapy Up for Panel Review on Feb. 19
February 6, 2025
-
COMMENTARY Companies Welcome Generic Drug Fund, but Fret Pricing and Regulations
February 5, 2025
-
BUSINESS Astellas to Revamp Management in April, Consolidate R&D Functions
February 5, 2025
-
ACADEMIA Medical Society Says “No” to Discontinuation of Theodur Despite Supply Struggle
February 5, 2025
-
REGULATORY PMD Act Set for Amendments Covering Issues Unaddressed over Past Decade: MHLW Official
February 4, 2025
-
BUSINESS Daiichi Sankyo Assigns COO Okuzawa as CEO from April
February 3, 2025
-
BUSINESS Julie Kim Tapped to Take Over Helm of Takeda in 2026
January 31, 2025
-
BUSINESS Takeda CEO Weber to Retire Next Year, Succeeded by US Head
January 30, 2025
-
BUSINESS Pfizer Japan Resolved to Drive Vaccine Demand, New Drug Launches: President
January 30, 2025
-
REGULATORY Pfizer’s Litfulo Braced for Price Cut after Cost-Effectiveness Assessment
January 30, 2025
-
REGULATORY MHLW Panel Finalizes NIP Inclusion of Shingles Jabs, OKs New Basic Immunization Plan
January 30, 2025
-
BUSINESS Nichi-Iko to Start Production Collaboration with Kyowa in FY2025: President
January 29, 2025
-
REGULATORY LDP-OK’ed Bill for PMD Act Amendment Specifies Launch of Innovative Drug Fund
January 28, 2025
ページ
As CEO of Morunda, I had the privilege of interviewing Bill Schuster, Country Manager of Viatris in South Korea. Our conversation delved into the multifaceted nature of leadership in the healthcare industry, exploring challenges, successes, and the power of authenticity.A…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…